Tempest Therapeutics TPST
Tempest Therapeutics: preliminary proxy statement
- Form
- PRE 14A
- Filed
- Importance
- Routine
- Accession
- 0001140361-25-043939
Not explained yet; the original is on EDGAR.
Preliminary proxy statement
Similar companies
Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.
- ProMIS Neurosciences PMN public float $30M, Jun 30, 2025
- Provectus Biopharmaceuticals PVCT public float $31M, Jun 30, 2025
- Cumberland Pharmaceuticals CPIX public float $29M, Jun 30, 2025
- Rockwell Medical RMTI public float $29M, Jun 30, 2025
- Champions Oncology CSBR public float $29M, Oct 31, 2025